Catalent
CTLT
#1585
Rank
A$16.33 B
Marketcap
$89.99
Share price
-0.18%
Change (1 day)
19.72%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of June 2024 : A$7.37 B

According to Catalent's latest financial reports the company's total debt is A$7.37 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30A$7.29 B19.61%
2022-06-30A$6.09 B40.39%
2021-06-30A$4.34 B-1.33%
2020-06-30A$4.40 B4.43%
2019-06-30A$4.21 B14.65%
2018-06-30A$3.67 B35.7%
2017-06-30A$2.70 B8.1%
2016-06-30A$2.50 B2.74%
2015-06-30A$2.43 B-15.21%
2014-06-30A$2.87 B-2.33%
2013-06-30A$2.94 B12.4%
2012-06-30A$2.62 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
A$59.96 M-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.50 B-93.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.68 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.33 B-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA